KARL STORZ has acquired T1V's medical division to enhance its digital surgery capabilities, integrating innovative visual collaboration technology into its CollaboratOR platform.

Target Company Information

KARL STORZ, a family-owned leader in medical technology, has announced the acquisition of T1V's medical division, a renowned US-based visual collaboration software company headquartered in Charlotte, North Carolina. This acquisition represents a strategic enhancement to KARL STORZ’s existing capabilities in integrated hardware and software solutions for digital surgery, especially in global operating rooms.

Since 2018, the CollaboratOR platform has been exclusively marketed through KARL STORZ, thus establishing a solid foundation for collaboration between the two companies. The acquisition will see KARL STORZ gain access to T1V's proprietary technologies and intellectual property, including patents related to visual collaboration software, further strengthening its portfolio in the healthcare technology market.

Industry Overview

The healthcare technology industry in the United States is rapidly evolving, primarily due to the increasing demand for innovative solutions that improve patient outcomes and operation

View Source

Similar Deals

Abbott Exact Sciences

2026

Other In-Vivo Diagnostic & Testing Substances United States of America
Edwards Lifesciences JenaValve Technology

2026

Other Medical Devices & Implants United States of America
Fortified Health Security Latitude Information Security

2026

Other Healthcare Facilities & Services (NEC) United States of America
Sofinnova Partners Hemab Therapeutics

2025

Other Bio Therapeutic Drugs United States of America
Knack RCM PPM Partners

2025

Other Healthcare Facilities & Services (NEC) United States of America
LPOXY Therapeutics, Inc. Xeno Biosciences Inc.

2025

Other Bio Therapeutic Drugs United States of America

KARL STORZ

invested in

T1V

in 2025

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert